Forums

HomeForumsVaccine Reactions

This forum contains 56 topics and 339 replies, and was last updated by  lisawinkler1 23 days ago.

Viewing 15 topics - 1 through 15 (of 56 total)
Topic Voices Posts Freshness
 
Hospital Pharmacy — GBS and Vaccination: Usually Unrelated 1 2

Started by:  GH

6 23 23 days

 lisawinkler1

Varicella-Zoster Virus: Another Trigger of GBS?

Started by:  GH

1 1 30 days

 GH

Archives of Internal Medicine — No Association between Immunization and GBS …

Started by:  GH

1 1 41 days

 GH

JAMA — GBS Following Influenza Vaccination

Started by:  GH

1 1 41 days

 GH

BioMed Central — Estimating background rates of GBS …

Started by:  GH

1 1 41 days

 GH

American Journal of Epidemiology — GBS study

Started by:  GH

1 1 70 days

 GH

British Medical Journal — GBS and H1N1 Vaccine

Started by:  GH

1 1 73 days

 GH

Kaiser Permanente press release — Vaccinations and GBS recurrence

Started by:  GH

1 1 73 days

 GH

Flu shot: Profit or politics?

Started by:  Mackie

2 2 74 days

 GH

Rabies Vaccine

Started by:  bailqueen

2 3 74 days

 GH

Shingles Vaccine – Gbs

Started by:  Myrt

3 3 74 days

 GH

Pneumonia Vaccine 1 2

Started by:  mjport

16 19 74 days

 GH

Has any one filed… 1 2

Started by:  Gemcutter

0 17 145 days

 Gemcutter

Getting gbs/cidp covered by the vaccine compensation fund

Started by:  gbs-mf-stroke

0 4 265 days

 gbs-mf-stroke

2009 Flu Shot Reactions in Canada

Started by:  D.U.

0 9 337 days

 D.U.

Viewing 15 topics - 1 through 15 (of 56 total)

You must be logged in to create new topics.

  • Centers of Excellence

  • Connect With Us

  • Topics of Interest

    research-grants

    Upcoming Special Events

    The GBS/CIDP Foundation of Canada is hosting the Canadian Eastern Conference in Halifax, Nova Scotia. This is your chance to learn about all aspects of GBS, CIDP and its variants from initial diagnosis to treatment and rehabilitation. Be sure to check our Community Events page for upcoming chapter meetings in a city near you.


    research-grants

    CSL Behring Announces Trial for CIDP Patients

    CSL Behring has announced that the first patient has been enrolled in the PATH study, an international clinical trial designed to evaluate the efficacy, safety, and tolerability of two different doses of subcutaneous immunoglobulin (SCIg), compared with placebo, in maintenance treatment of chronic inflammatory demyelinating polyneuropathy (CIDP).


    research-grants

    May is GBS/CIDP Awareness Month

    During the month of May, in an effort to increase awareness in each of our communities, we encourage everyone to organize activities that highlight GBS, CIDP and their variants. Throughout the world, individuals and groups have organized fundraising events such as walks, runs, bake sales, fashion shows, cocktail receptions, and art shows.
Subject: Question: